Brave risk helps women cheat death

Rosemary Rathbun and Lorrine Rodgers call what’s happened a miracle.

It’s easy to understand why.

Both Las Vegas grandmothers suffered from cancers that appeared ready to take their lives. Rathbun had been told she should enroll in hospice.

But now, thanks to their participation in the first in-human trial of an antibody drug with the unwieldly code name MPDL3280A, the women are cancer-free.

Their oncologist, Dr. Fadi Braiteh, said the new drug unleashed each woman’s own immune system to attack their cancer cells.

“We’re now in a field of cancer treatment known as immunotherapy,” said Braiteh as he sat in an examination room with Rathbun at the Comprehensive Cancer Centers of Nevada Central Valley treatment site on Eastern Avenue. “What’s wonderful about this treatment, what’s so dramatic, is that there don’t appear to be side effects.”

Both the 78-year-old Rathbun and the 56-year-old Rodgers experienced side effects, sometimes severe, from what have been the traditional treatments for cancer: surgery, chemotherapy and radiation.

In July 2009, Rathbun, once a smoker, was diagnosed with throat cancer. Not only did chemotherapy make her “very sick” with nausea and its effects, she said the radiation “fried her throat.”

Even today, said the woman whose cancer later spread to the neck and breast, she’s limited to soft foods.

“For eight months, all I could tolerate was Ensure (nutritional shakes and drinks),” she said.

Rodgers, a hotel housekeeper on the Strip, said the chemotherapy and radiation for her breast cancer caused her to miss three months from work and even more when the cancer spread to her neck. She added that she felt so sickened and weakened by the treatment that she sometimes wonders how she managed to get through a day when she did return to work.

“I couldn’t take off too much time because I’d lose my job,” she said recently as she sat next to her husband in their Las Vegas home.

Given their difficult experiences with what is considered state-of-the-art treatments — losing their hair was the least of their concerns — it isn’t surprising that both women had acute trepidation about trying an unproven therapy with unknown reactions for humans.

They went into uncharted territory, even fearing effects worse than before, because giving into death without using one more possible weapon to stave it off wasn’t attractive to them or their families.

Taking the step put them on an emotional roller coaster — they were riddled with fear one minute, filled with hope the next.

“I did a lot of holding of Lorrine then,” Nelson Rodgers said of his wife. “There were a lot of tears. It was a frightening time.”

To the women’s amazement, the therapy, delivered through an IV for a couple of hours once every three weeks, didn’t sicken them.

“I could go to work without a problem,” Lorrine Rodgers said.

After just six treatments of a 16-treatment regimen, scans already show Rodgers free of cancer.

Rathbun’s yearlong experience with the drug beginning in 2012 was just as easy.

“I couldn’t believe it,” she said. “I went for a few times and the cancer left me.”

Braiteh sounds as amazed as his patients about the drug trial that’s been going on in Southern Nevada and at 17 others sites across the world for about a year.

“It’s incredible,” he said. “Now we have to find out why this therapy works so well on some people and not on others.”

About half of the 15 people on the phase 1 drug trial in Southern Nevada, Braiteh said, have experienced some positive results, which means tumors shrank or cancers did not progress, or, as in Rodgers and Rathbun’s case, cancer disappeared.

“I also had some bladder cancer patients who are now cancer-free,” he said.

Whether his cancer-free patients stay that way is unknown, Braiteh said.

“That is a question we don’t have the answer to.”

Results in Las Vegas have been more positive than those experienced at Yale Cancer Center in New Haven, Conn., the drug’s lead trial site.

A 2013 study of 140 patients there found that 21 percent experienced significant tumor shrinkage. The highest number of positive responses were in patients with lung cancer and melanoma.

What has frustrated researchers for decades is cancer cells’ ability to evade the immune system. Why, researchers wondered, did white blood cells in the lab always kill cancer cells but not in the body?

In recent years, scientists not only learned the answer — cancerous tumors wrap themselves in an invisible molecular shield or camouflage — they also learned that certain drugs could break through the shield.

If the immune system is free to do its job, what researchers have long seen in laboratory Petri dishes — white blood cells attacking cancer cells — can occur in the body, too.

To date, several drugs have been tested to free the immune system. Studies have shown their effectiveness in treating several types of cancers, including breast cancer, melanoma, ovarian cancer and cancers of the head and neck, colon and stomach, but not the prostate.

MPDL3280A, manufactured by Roche Genentech, is designed to prevent a cancer cell’s overexpressed PD-L1 protein from putting the immune system to sleep. By blocking the interaction between PD-L1 and the immune system, the drug boosts a patient’s anti-cancer immune response.

“With this approach, we can take the cancer out from behind the camouflage — that’s what PD-L1 is — and we’re not using anything toxic,” Braiteh said. “That’s what is so brilliant about this approach. We’re just letting the immune system do its job.”

Braiteh couldn’t be happier that cancer fighters now have weapons that don’t produce what he calls “collateral damage.”

“Cancer is a cell of the body that goes nuts,” he explained. “It is what a zombie or vampire is to a human being. And unfortunately what kills cancer cells also kills normal cells. Chemo is like napalm.”

MPDL3280A works best, Braiteh said, on patients who had tumors that had high numbers of cancer cells expressing PD-L1.

“We test people for PD-L1 to see if they should be part of the trial,” he said, adding that the drug trial’s phase 1 continues to recruit patients. Those wishing to join the research study should phone 702-952-3400.

Braiteh said breast cancer patients with the triple negative form of the disease, which Rodgers had, have benefited in the trial.

Although both patients and doctors understandably want progress to quicken for cancer treatment drugs, Braiteh noted the first Federal Drug Administration-approved drug came in 1949.

“Medical oncology is a young field, ” he said.

Exciting to researchers studying MPDL3280A, Braiteh said, is its efficacy in dealing with lung cancer, which has been extremely difficult to treat and becomes incurable once it has spread to other parts of the body.

In September, Europeans were so excited about the results of trials among lung cancer patients — 26 percent of patients responded to treatment — that the head of the European Cancer Congress, professor Cornelis van de Velde said: “Hundreds of millions of euros have been spent chasing the dream of immunotherapy for lung cancer patients, but with zero results.

“These early findings on the effect of the anti-PD-L1 monoclonal antibody, MPDL3280A, suggest that it has the potential to open new therapeutic approaches, particularly for smokers and former smokers.”

Braiteh said a phase 2 study of the drug, focusing on people with lung cancer, is underway in Las Vegas. Five people are being treated with the drug.

“Lung cancer has been a particularly difficult cancer for researchers to deal with,” he said.

Any kind of cancer, Rathbun said, is hard for patients to deal with.

“I’ll never forget when my doctor said I should get into hospice,” she recalled, weeping. “You don’t know what it’s like to be told your life is over. And then along comes this experimental drug. And now I have hope. When you’re a cancer patient, hope is all you’ve got.”

Reporter Paul Harasim can be reached at or 702-387-2908.

MAGIC fashion convention showcases men's clothing trends
The MAGIC fashion convention has come to Las Vegas at the Mandalay Bay Convention Center to showcase some of the hottest clothing trends for men. (Nathan Asselin/Las Vegas Review-Journal)
Former Army medic’s Afghanistan story told in new book
The graphic novel “Machete Squad” is based on journals written by Las Vegan Brent Dulak.
Las Vegas man talks about losing his wife
Dwayne Murray, 37, lost his wife, LaQuinta while she was at Centennial Hills Hospital. A jury awarded him $43 million last week after it said the hospital failed to perform the standard of care in administering a drug for her sickle cell disease.
Barber sets up shop in grandfather’s old shop
Andres Dominguez’s new barber shop is filled with memories of his grandfather, who ran the El Cortez landmark for more than 30 years. (John Przybys/Las Vegas Review-Journal)
Life and times of a 90-year-old horse player
Leo Polito of Las Vegas describes meeting legendary jockey and trainer Johnny Longden on the beach at Del Mar. Mike Brunker/Las Vegas Review-Journal.
Learning the history of singing bowls
Presentation at Summerlin Library teaches residents about the history of singing bowls (Mia Sims/Las Vegas Review-Journal)
Learning live-saving techniques in Stop the Bleed class
Leslie Shaffer, an AMR paramedic, shows how to control bleeding during a Stop the Bleed course at the Summerlin Library. The class is designed to teach anyone how to control and stop life-threatening bleeding. (Mia Sims/Las Vegas Review-Journal)
Vicki Richardson speaks about on the power of art
Artist and arts advocate Vicki Richardson talks about the power of art to inspire and challenge. (John Przybys/Las Vegas Review-Journal)
DressCoders pairs tech with haute couture
DressCoders is a startup focused on haute couture garments. The company uses illuminated thread that is washable and can be sewn right into the fabric. (Mat Luschek/Las Vegas Review-Journal)
CES 2019: Brava infrared oven
In cooking with the Brava infrared oven,there’s no preheating. the bulbs can reach 500 degrees in less than a second. (Heidi Knapp Rinella/Las Vegas Review-Journal)
Sinks Merge Style And Utility
Study could determine cause of Alzheimer’s, Parkinson’s diseases
Dr. Aaron Ritter, director of clinical trials at the Cleveland Clinic Lou Ruvo Center for Brain Health, discusses his research on how inflammation in the brain impacts Alzheimer’s and Parkinson’s diseases. (Jessie Bekker/Las Vegas Review-Journal)
Holocaust survivors talk about tragedy and friendship
Janos Strauss and Alexander Kuechel share their perspectives on life. (John Przybys/Las Vegas Review-Journal)
'Siegel Cares' Santa delivers toys to kids at Siegel Suites in Las Vegas
Siegel Cares, the charitable wing of The Siegel Group, delivered toys to families at their apartment complexes in Las Vegas. (K.M. Cannon/Las Vegas Review-Journal)
Revisiting “Christ the King” sculpture
A longtime admirer of the sculpture at Christ the King Catholic Community in Las Vegas shares her perspective. (Bizuayehu Tesfaye/Las Vegas Review-Journal @bizutesfaye)
Henderson couple adds another school to their generosity
Bob and Sandy Ellis of Henderson, who donate to several Clark County School District schools, have added Matt Kelly Elementary in Las Vegas to their list of schools where every student gets new shoes, socks and a toy. (K.M. Cannon/Las Vegas Review-Journal)
Terry Fator Christmas House
Arguably better than a hotel holiday display, is Terry and Angie Fator's home located in southwest Las Vegas.
UNLV Winter Graduation Packs Thomas & Mack
UNLV's 55th winter commencement ceremony included approximately 2,146 undergraduate and graduate students who recently completed their studies. (Benjamin Hager/Las Vegas Review-Journal)
Build-A-Bear comes to Reed Elementary School
Students participated in a Build-A-Bear-Workshop at Doris Reed Elementary School in Las Vegas, Thursday, Dec. 13, 2018.
Rev. Father Seraphim Ramos talks about Greek Orthodox icons during an interview with the LVRJ
Rev. Father Seraphim Ramos talks about Greek Orthodox icons during an interview with the Las Vegas Review-Journal at St. John the Baptist Greek Orthodox Church. Bizuayehu Tesfaye/Las Vegas Review-Journal @bizutesfaye
Masjid Ibrahim Islamic Center art depicts names of God
Masjid Ibrahim Islamic Center founder Sharaf Haseebullah talks about new diamond-shaped art panels featuring some of the 99 names of Allah at the main entrance the Las Vegas mosque. (K.M. Cannon/Las Vegas Review-Journal)
Holiday poultry with Tim and Chemaine Jensen of Village Meat & Wine
Tim and Chemaine Jensen of Village Meat & Wine explain the different types of poultry available for the holidays. (Heidi Knapp Rinella/Las Vegas Review-Journal)
Catholic Charities hosts early Christmas meal
Students from the Bishop Gorman High School football and cheerleader team helped to serve food at the Christmas meal sponsored by the Frank and Victoria Fertitta Foundation at Catholic Charities of Southern Nevada on Sunday. (Rachel Aston/Las Vegas Review-Journal)
Incarcerated Christmas
This is the fourth year HOPE for Prisoners has worked with the Nevada Department of Corrections to create a Christmas for prisoners to visit their families. (Rachel Aston/Las Vegas Review-Journal)
2018 Homeless Vigil
Straight From The Streets holds its 23rd annual vigil to remember the 179 homeless individuals who died in Clark County this year.
Getting through the Holiday blues
Psychologist Whitney Owens offers advice on keeping your mental health in check during the Holiday season in Henderson, Thursday, Dec. 13, 2018. (Caroline Brehman/Las Vegas Review-Journal)
Operation Homefront Holiday Meals for Military
Operation Homefront Holiday Meals for Military program gave meal kits to 200 families at Veterans of Foreign Wars Post 10047 in Las Vegas Wednesday, Dec. 12, 2018. It all started with a chance encounter in a supermarket in Utica, N.Y., near Fort Drum. A soldier, his wife and infant had a handful of grocery items they couldn't afford. A Beam Suntory employee picked up the $12 cost for the groceries. The program has grown from providing 500 meal kits to military families in 2009 to providing more than 7,000 nationally this holiday season.K.M. Cannon Las Vegas Review-Journal @KMCannonPhoto
An elegant Tea Party for substance abuse and homeless women
An elegant Tea Party for substance abuse and homeless women at WestCare Women Children Campus in Las Vegas. Bizuayehu Tesfaye/Las Vegas Review-Journal @bizutesfaye
Former 51s manager Wally Backman chats about new job
Former Las Vegas 51s manager Wally Backman talks about his new job with the independent league Long Island Ducks during the Baseball Winter Meetings in Las Vegas, Nevada, on Dec. 10, 2018. (Ron Kantowski/Las Vegas Review-Journal)
Inside the kitchen at Springs Preserve
The staff of Divine Events do party preparation in the kitchen at Divine Cafe at Springs Preserve. With nine parties the following day, this is a particularly busy time for the crew. (Heidi Knapp Rinella/Las Vegas Review-Journal)
News Headlines
Home Front Page Footer Listing